Biotechnology modeling and simulation software company Simulations Plus Inc. in Lancaster announced Thursday a funded collaboration with an unnamed animal health company.
The goal of the partnership is to add new species to Simulations’ GastroPlus platform, a modeling software that allows clients to simulate the exposure of pharmaceutical drugs and environmental chemicals in humans and animals.
“This new collaboration will extend GastroPlus functionality to modern animal agriculture and support veterinary medicine and food production research,” Dr. Viera Lukacova, Simulations’ division chief scientific officer, said in a statement. “We are excited to begin working with our partner and leverage their expertise and the unique data they will be sharing to develop the next generation of tools which will promote the health and welfare of animals and the general public.”
Financial terms of the collaboration were not disclosed.
Simulations Plus Division President John DiBella called the collaboration an important milestone for the company.
“The importance of these collaborations cannot be overstated, and we will continue to pursue future collaborations across our entire suite of software programs to drive innovation and advance modeling and simulation science,” DiBella said in a statement.
Shares of Simulations Plus (SLP) closed Thursday down 89 cents, or nearly 1.9 percent, to $46.89 on the Nasdaq, a market that closed down 2.5 percent.
